Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.

about

Comprehensive graphical presentation of data from incurred sample reanalysis.

P2860

Q36408793-A837CA75-2BEB-4B9F-BDDF-6AEBFB1A0399

P2860

Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.

Item

http://www.wikidata.org/entity/Q35803449

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@ast

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@en

type

Item

label

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@ast

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@en

prefLabel

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@ast

Validated HPLC-UV method for d ...... nst ibuprofen and paracetamol.

@en

P1476

Validated HPLC-UV method for d ...... inst ibuprofen and paracetamol

@en

P2093

Iwona Szlaska

http://www.w3.org/2001/XMLSchema#string

Monika Filist

http://www.w3.org/2001/XMLSchema#string

P2860

A turbulent decade for NSAIDs: update on current concepts of classification, epidemiology, comparative efficacy, and toxicity

Bioequivalence study of three ibuprofen formulations after single dose administration in healthy volunteers

The pharmacokinetics of naproxen, its metabolite O-desmethylnaproxen, and their acyl glucuronides in humans. Effect of cimetidine

Development and validation of a sensitive and high-throughput LC-MS/MS method for the simultaneous determination of esomeprazole and naproxen in human plasma.

Pharmacokinetic comparison study of a combination containing 500 mg of Naproxen and 20 mg of Esomeprazole: a randomized, single-dose, 2-way crossover, open-label study in healthy Korean men.

Comparative in vitro dissolution and in vivo bioavailability of diflunisal/naproxen fixed-dose combination tablets and concomitant administration of diflunisal and naproxen in healthy adult subjects.

Bioavailability of two oral-tablet and two oral-suspension formulations of naproxen sodium/paracetamol (acetaminophen): single-dose, randomized, open-label, two-period crossover comparisons in healthy Mexican adult subjects.

HPLC method for naproxen determination in human plasma and its application to a pharmacokinetic study in Turkey.

Absence of pharmacokinetic interaction between orally co-administered naproxen sodium and diphenhydramine hydrochloride.

Linear regression for calibration lines revisited: weighting schemes for bioanalytical methods.

P304

953-961

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/BMC.3635

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

M Kaza

Tomasz Pawinski

P577

2015-11-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26458096

http://www.w3.org/2001/XMLSchema#string

Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.

about

P2860

P2860

Validated HPLC-UV method for determination of naproxen in human plasma with proven selectivity against ibuprofen and paracetamol.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698